Introduction
Depression remains a leading cause of disability worldwide (Kessler et al., 2003) , yet our understanding of the neurobiology of this disorder and treatment response remains incomplete. Furthermore, the time lag of current medications to produce antidepressant effects (Greenberg et al., 2015) , and the existence of high rates of non-responsive patients (Fournier et al., 2010) Immunofluorescence labeling was performed on fixed brain tissues using standard techniques.
Brains were collected from mice after transcardiac perfusion with saline and 4% paraformaldehyde (PFA). Brains were post-fixed in 4% PFA for 24 hours and incubated in 30% sucrose for an additional 48 hours. Fixed brains were frozen and sectioned at 25 um using a Microm HM550 cryostat. Free-floating sections were washed, then blocked for 1 hour at room temperature followed by incubation with primary antibody. Primary antibodies: guinea pig anti-VGAT (Synaptic system-131004), guinea pig anti-VGLUT 1 (Synaptic system-135304), rabbit anti-VGLUT 2 (Synaptic system-135403). Washed sections were then incubated with secondary antibodies (Alexa Fluor 568-conjugated goat anti-guinea pig IgGs #A21450 or Alexa Fluor 647-conjugated goat anti-rabbit IgGs #A11011 (Life Technologies).
Sections were washed, mounted on glass slides and coverslipped with Prolong Gold Anti-fade reagent (Life Technologies).
High-resolution images were acquired using an Olympus (FV1000) laser scanning confocal microscope using a 60x oil-immersion objective (N.A. 1.42) with optimized pinhole diameter. Z-stack images (16-bit depth) were collected using 0.3 um step size, 3x digital zoom, 2 us/pixel scan speed, 800 x 800 image size and 0.088 um x 0.088 um pixel size in xy.
Laser intensity, photomultiplier amplification and offset were optimized for maximum dynamic range with no saturated pixels and were held constant for all image collection. Image stacks were deconvolved (AutoQuant X v.3.0.1, Media Cybernetics) and quantitative analysis was performed on thresholded images in ImageJ. Images were binarized using a threshold that was determined in an initial survey of images, to optimize the detection of moderate to bright label intensity while maximizing the visual separation of object masks. For a given label, the resulting threshold value was held constant for the analysis of the entire image set. Watershed segmentation was applied in ImageJ and particle analysis was set to include labelled structures < 2.3 for VGAT and VGLUT1, and < 3.8 um 2 for the larger VGLUT2 terminals, Journal Pre-proof J o u r n a l P r e -p r o o f 7 consistent with reported sizes for these axon terminal boutons in mouse cortex (Nakamura et al., 2005) . Two to four images were collected per cortical layer in each tissue section and were averaged from 1-2 tissue sections to give a value per animal for each layer.
Brain slice preparation and electrophysiology
For the analyses of layer V pyramidal cells, mPFC brain slices were prepared as described previously (Li et al., 2011) with minor modifications. During recording, cells were voltage clamped at -65 mV to simultaneously record inhibitory and excitatory postsynaptic currents (IPSCs and EPSCs). The PSC responses were tested in brain slices 24 hours following in vivo injection of saline or ketamine (10mg/kg). Sst-tdT cells were recorded as previously described (Wohleb et al., 2016) . Recordings of the ChR2-positive GAD cells were performed at least two weeks following virus injection as detailed in the supplementary materials.
Virus Injection and Optical Manipulation
Bilateral infusions of purified double floxed AAV2-EF1a-DIO-hChR2(H134R)-eYFP or floxed AAV2-EF1a-DIO-Arch-eYFP viruses were made in Gad-Cre positive and littermate wildtype mice at AP: +1.9, ML -0.2, DV -2.7 with immediate placement of optical fibers (200 µm core, 0.22NA, Doric Lenses). Optical stimulations were for 60 min (473 nm laser: 15 ms pulse width, 5 Hz, 5 mW at the tip of the fiber, 1 min on and 1 min off for 30 cycles) or (590 nm laser: 5 Hz, 1-3 mW at the tip of the fiber, continuous for 60 min).
J o u r n a l P r e -p r o o f 8 differences between group-means were determined by Bonferroni or Fisher's LSD post hoc tests. Significance was determined at P < 0.05. Viral expression and implant placement were verified before mice were included in the analysis.
Results

Ketamine and CUS induce opposite effects on GABAergic and glutamatergic synaptic
proteins.
Previous studies have demonstrated that a single dose of ketamine produces rapid and sustained antidepressant effects in rodent models consistent with the antidepressant effects in depressed patients (see Duman et al., 2016) . These behavioral effects are associated with activity dependent, rapid and sustained increases in synapse number and function in the PFC (Duman et al., 2016). In the current study we examined the influence of CUS and a single dose of ketamine on behavior and GABA and glutamate synaptic proteins in male mice 24 hr after ketamine dosing. Behavioral studies were conducted to confirm a CUS-induced depressive phenotype. CUS significantly increased immobility in the FST (Figure 1b ) and the latency to feed in a novel environment ( Figure 1c ). Moreover, a single dose of ketamine significantly decreased both the immobility time in the FST and latency to feed in the NSFT in control as well as CUS mice (Figure 1b , c). There were no changes in baseline locomotor activity measured on day 25 or in home cage feeding which was measured for 24 hours following the NSFT (Figure 1d , e).
To identify possible abnormalities in neural inhibition linked to these behaviors, we measured GABAergic synapse-associated proteins in the PFC; levels of glutamate markers were also examined for comparison. Levels of vesicular GABA transporter (VGAT), GABA synthetic enzymes (GAD65 and GAD67), and GABA-A receptor associated postsynaptic protein (gephyrin) were determined by western blot of PFC synaptoneurosomes. CUS J o u r n a l P r e -p r o o f exposure significantly decreased levels of GAD67, and gephyrin, and this effect was reversed by a single dose of ketamine for both GAD67 and gephyrin ( Figure 1g ). A significant main effect of ketamine was observed for all of the GABAergic markers tested ( Figure 1g ).
Analysis of glutamate markers included the two major vesicular transporters, VGLUT1 and VGLUT2, which play an important role in the uptake of glutamate into presynaptic vesicles (Fremeau et al., 2001) , and the postsynaptic protein PSD95. In the present study, CUS exposure significantly decreased levels of VGLUT1 and this effect was reversed by ketamine ( Figure 1h ). Ketamine also significantly increased levels of VGLUT2 and PSD95 ( Figure 1h ). We have previously reported the effect of CUS to decrease levels of GluR1 and PSD95 (Li et al., 2011) .
We also used immunohistochemical labeling for the vesicular transporters to examine the effects of CUS and ketamine and obtained results consistent with the western blot findings. These studies were conducted in Thy1-GFP mice to allow visualization of the layer J o u r n a l P r e -p r o o f CUS exposure significantly decreased the density of VGLUT1 puncta in mPFC (layers I, and II/III) and ketamine treatment normalized these effects (Figure 2c ', d). The density of VGLUT2 puncta was decreased by CUS (layer V), and ketamine normalized this effect (Figure 2e ', f). Higher magnification images from layer I of mPFC show immuno-labelled puncta for VGLUT1 and VGLUT2 in close apposition with GFP-labelled dendrites ( Figure   2h , upper and lower panels respectively). These sites of apparent contact suggest the possibility that ketamine and CUS effects on glutamatergic inputs to mPFC could be directly transmitted to layer V pyramidal cells; further studies are needed to confirm direct apposition onto dendrites. We also examined somatosensory cortex (S1) and found similar trends for CUS to decrease and ketamine to increase immuno-labelling for the vesicular transporters ( Supplementary Figure 1) , indicating that these effects may not be selective for mPFC. We also examined the vesicular choline transporter (VCHAT) and found that CUS and ketamine had no effects on VCHAT puncta in layer I, II, and III, and actually increased levels in layer V of mPFC, suggesting differential effects compared to what was observed with VGAT, To determine whether these effects were specific to pyramidal cells, we also recorded from SST interneurons. In SST-tdTomato reporter mice, we found that SST+ neurons are There was no effect of GABA interneuron inhibition under these conditions on immobility in the FST or latency to feed in the NSFT in the Gad1-Cre+ mice (Figure 5i , j).
Discussion
In this study, we identify specific CUS-induced deficits of GABA neurotransmission in the mPFC that are associated with alterations of neuronal function and show that a single dose of ketamine rapidly reverses these deficits as well as associated behavioral changes.
These findings extend previous studies, describing deficits of GABA interneurons that could Optogenetic studies to test the influence of GABA interneuron stimulation on depression-like behaviors were inconclusive (nonequivalent results for the FST and NSFT), while the results with optogenetic inhibition were negative. Gad1+ interneurons in mPFC were either stimulated or inhibited and behavioral tests were initiated the next day to avoid the acute effects of cell manipulation; this paradigm is based on our previous report that 1 hr stimulation (1 min on, 1 min off) of mPFC pyramidal neurons is sufficient to produce sustained antidepressant actions (Fuchikami et al., 2015) . The 1 hr time point was also chosen to avoid possible tissue damage caused by more long-term laser exposure, although it is possible that the 1 hr paradigm is too short, and that more sustained or repeated stimulation or inhibition paradigms are needed to induce sustained alterations of GABA function and behavior. It is also possible that targeting a specific subtype of GABA interneuron, notably Figure 6 ). Further characterization of the neurotransmitter receptors that control GABA function could lead to new insights for targeting GABA interneurons that will provide alternative and more efficacious therapeutic strategies for the treatment of depression. In addition, future studies are needed to determine if chronic stress causes sexspecific effects on GABA function (e.g., greater loss of GABA function in females compared to males) that could contribute to the increased incidence of depression in women compared to men. Together, these studies could identify novel therapeutic targets for the the development of more efficacious antidepressant treatments for men and women. There was no effect of laser inhibition of GABA interneurons in the mPFC on immobility time in the FST ( (i) or latency to feed in the NSFT (j). Results are ±S.E.M. n=4-6/ group. 
